Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$371.70M
Total Bought:
$50.13M
Total Sold:
$69.79M
Net Transaction:
-$19.66M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)39,72229,821-9,901$26.85M$35.77M9.62%+$8.92M
Merck & Co., Inc.(MRK)33,853189,357+155,504$22.92M$24.33M6.55%+$1.42M
Johnson & Johnson(JNJ)92,37785,425-6,952$11.94M$21.70M5.84%+$9.75M
AbbVie Inc.(ABBV)108,18164,325-43,856$10.39M$16.19M4.35%+$5.80M
CVS Health Corporation(CVS)23,773146,102+122,329$9.27M$15.11M4.07%+$5.85M
Thermo Fisher Scientific Inc.(TMO)22,98627,859+4,873$14.45M$13.97M3.76%-$482.6K
Revolution Medicines, Inc.(RVMD)617,24573,077-544,168$9.08M$13.69M3.68%+$4.61M
Biogen Inc.(BIIB)062,781+62,781$0$13.56M3.65%+$13.56M
Neurocrine Biosciences, Inc.(NBIX)89,68572,898-16,787$7.85M$12.29M3.31%+$4.43M
Mirum Pharmaceuticals, Inc.(MIRM)195,768100,807-94,961$9.40M$11.80M3.17%+$2.40M
Alkermes plc(ALKS)242,473213,329-29,144$8.24M$11.18M3.01%+$2.94M
Ionis Pharmaceuticals, Inc.(IONS)27,873137,131+109,258$9.40M$10.87M2.93%+$1.47M
BeOne Medicines AG(ONC)41,71735,180-6,537$12.14M$10.03M2.70%-$2.11M
Intuitive Surgical, Inc.(ISRG)70,85124,656-46,195$9.44M$9.81M2.64%+$360.4K
Stryker Corporation(SYK)26,83530,283+3,448$9.58M$9.53M2.57%-$45.4K
Vertex Pharmaceuticals Incorporated(VRTX)22,98419,131-3,853$11.17M$9.50M2.56%-$1.67M
EDWARDS LIFESCIENCES CORP106,518103,230-3,288$8.27M$9.34M2.51%+$1.07M
BridgeBio Pharma, Inc.(BBIO)111,363124,707+13,344$11.89M$9.29M2.50%-$2.61M
Krystal Biotech, Inc.(KRYS)37,57924,019-13,560$6.79M$8.93M2.40%+$2.13M
CENCORA INC23,47031,126+7,656$6.60M$8.81M2.37%+$2.20M
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
94,796248,848+154,052$5.51M$8.43M2.27%+$2.93M
ABIVAX Société Anonyme(ABVX)31,59058,170+26,580$4.78M$7.75M2.09%+$2.97M
Incyte Corporation(INCY)50,79656,953+6,157$7.97M$6.46M1.74%-$1.52M
iRhythm Holdings, Inc.(IRTC)22,32254,102+31,780$6.26M$6.44M1.73%+$175.8K
Boston Scientific Corporation(BSX)40,432146,381+105,949$8.84M$6.25M1.68%-$2.60M
Insmed Incorporated(INSM)97,43858,378-39,060$5.96M$6.22M1.67%+$269.2K
Tango Therapeutics, Inc.(TNGX)29,915198,557+168,642$3.63M$6.21M1.67%+$2.58M
Gilead Sciences, Inc.(GILD)47,96746,142-1,825$7.16M$5.83M1.57%-$1.33M
Cardinal Health, Inc.(CAH)108,68223,630-85,052$4.77M$5.61M1.51%+$845.3K
Oruka Therapeutics, Inc.(ORKA)054,886+54,886$0$5.22M1.41%+$5.22M
Spyre Therapeutics, Inc.(SYRE)62,73557,030-5,705$3.49M$5.06M1.36%+$1.58M
DexCom, Inc.(DXCM)584,33271,846-512,486$2.64M$4.84M1.30%+$2.20M
BICARA THERAPEUTICS INC1,169,634145,657-1,023,977$2.32M$4.32M1.16%+$2.01M
IDEAYA Biosciences, Inc.(IDYA)31,13394,478+63,345$4.01M$3.52M0.95%-$490.3K
Celcuity Inc.(CELC)141,29633,313-107,983$5.14M$3.49M0.94%-$1.66M
Disc Medicine, Inc.(IRON)107,25543,682-63,573$3.19M$3.19M0.86%+$6.2K
Pyxis Oncology, Inc.(PYXS)197,036966,459+769,423$1.62M$2.91M0.78%+$1.29M
Compass Therapeutics, Inc.(CMPX)41,8311,048,593+1,006,762$3.05M$2.30M0.62%-$754.6K
JADE BIOSCIENCES088,556+88,556$0$1.97M0.53%+$1.97M
Amgen Inc.(AMGN)21,9030-21,903$8.72M$0—-$8.72M
SOLENO THERAPEUTICS INC90,1840-90,184$2.21M$0—-$2.21M
UnitedHealth Group Incorporated(UNH)14,6360-14,636$2.77M$0—-$2.77M
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q2 2026 | TickerTrail